Time-Restricted Feeding Improves Crohn's Disease Activity in New Trial

A simple kitchen table with a plate of food next to a clock showing an eight-hour window, natural morning light through a window

Can Time-Restricted Eating Help Manage Crohn’s Disease?

Yes, in a small pilot trial. In 35 adults with Crohn’s disease who were overweight, eating within an 8-hour window for 12 weeks lowered clinical disease activity, BMI, belly (visceral) fat and markers of systemic inflammation, compared with standard management. BMI fell by 0.9 kg/m² in the time-restricted group and rose slightly in the control group. Participants were not asked to change what they ate, only when.

Crohn’s disease is a type of inflammatory bowel disease that causes pain, cramping, and digestive problems. Most treatments involve powerful drugs that suppress the immune system. But this new trial, published in the journal Gastroenterology, suggests something much simpler could help: just changing when you eat, not what you eat. A Canadian team tested whether limiting meals to an 8-hour window each day could improve symptoms and metabolic markers in Crohn’s patients.

Dr. Kumar’s Take

Time-restricted eating is already known to help with weight and metabolic health, and seeing Crohn’s disease activity improve in a randomized trial is a real signal. What makes this trial stand out is that participants were not asked to cut calories or follow a special diet. They simply ate within an 8-hour window. That kind of simplicity matters for patients who are already dealing with a demanding chronic illness.

The caveat belongs right next to the result: this was a pilot with 35 participants over 12 weeks. In an early report of the trial, the change in disease activity score was only a trend. As a low-risk addition to standard treatment it is worth watching, but it needs larger trials.

Study Snapshot

Researchers in Calgary and Kelowna enrolled adults with Crohn’s disease and a BMI above 25. Thirty-five completed the study: 20 in the time-restricted feeding group and 15 in a standard management group. The time-restricted group fasted for 16 consecutive hours a day, 6 days a week, eating all their meals within an 8-hour window. The control group kept their usual eating habits. Neither group was asked to change what foods they ate. The trial lasted 12 weeks, and researchers tracked disease activity, body mass index, visceral fat (the deep belly fat linked to inflammation), stool markers, and blood markers of inflammation and metabolism.

Results in Context

Body mass index fell 0.9 kg/m² in the fasting group and rose slightly in controls. The published paper reports that time-restricted feeding lowered clinical disease activity, measured with the Harvey-Bradshaw Index.

Visceral fat fell by 194 cm³ in the fasting group and rose by 78 cm³ in controls, according to an early report of the trial presented at a 2025 Canadian gastroenterology meeting. The same report found that leptin, plasminogen activator inhibitor-1, and adipsin, hormones and proteins released by fat tissue, fell significantly with time-restricted feeding. Serum amyloid A, a blood marker of inflammation, also fell, and fecal calprotectin, a stool marker of gut inflammation, held steady or dropped. In the control group, these markers rose.

Who Benefits Most

This trial enrolled adults with Crohn’s disease who were overweight, so the results apply most directly to that group. Time-restricted eating is also appealing because it asks very little of patients. Unlike elimination diets or complex meal plans, it only requires adjusting the timing of meals. That said, people with Crohn’s who are underweight or malnourished should be cautious, since limiting eating windows could make it harder to get enough nutrition.

Safety, Limits, and Caveats

This was a small pilot trial with just 35 participants, so the results need to be confirmed in larger studies. It enrolled people who were overweight, so it says little about people with Crohn’s who are at a normal weight or underweight. The 12-week duration also leaves open questions about whether the benefits last over months or years. It is also important to note that this approach was tested against standard management, not as a replacement for medical care. Anyone with Crohn’s disease should talk to their gastroenterologist before making changes to their eating patterns.

Practical Takeaways

  • If you have Crohn’s disease and want to try time-restricted eating, talk to your gastroenterologist first to make sure it fits safely with your current treatment plan.
  • This trial used an 8-hour eating window, 6 days a week. A window such as 10 a.m. to 6 p.m. is one common way to set that up.
  • In this trial, people were not asked to change what they ate or count calories, only when they ate.
  • Track your symptoms for several weeks to see if the timing change makes a noticeable difference before deciding whether to continue.

FAQs

Is time-restricted feeding the same as intermittent fasting?

Time-restricted feeding is one form of intermittent fasting. While intermittent fasting is a broad term that covers many different patterns, including alternate-day fasting and 5:2 diets, time-restricted feeding specifically means eating all your food within a set window each day, usually 6 to 10 hours. The approach used in this Crohn’s trial was an 8-hour eating window. Unlike some fasting methods, time-restricted feeding does not require skipping entire days of eating, which makes it easier for most people to follow consistently.

Can time-restricted eating replace medication for Crohn’s disease?

No. This trial compared time-restricted feeding with standard management. It did not test meal timing as a replacement for treatment. While the results are encouraging, there is no evidence yet that changing meal timing alone can control Crohn’s disease without medication. Stopping or reducing medication without medical guidance can lead to serious flares and complications. Think of time-restricted eating as a potential add-on tool, not a substitute for proven therapies.

Could time-restricted feeding help with other types of inflammatory bowel disease like ulcerative colitis?

This trial specifically studied Crohn’s disease, so the results cannot be directly applied to ulcerative colitis or other forms of IBD. However, the fact that time-restricted feeding lowered adipokines and reduced visceral fat suggests the mechanism could benefit other inflammatory conditions as well. Visceral fat is known to release inflammatory chemicals that affect the entire body, not just the gut. Future trials will need to test whether these benefits extend to ulcerative colitis patients, who have a different pattern of gut inflammation than those with Crohn’s disease.

Bottom Line

This small randomized trial found that eating within an 8-hour window each day lowered Crohn’s disease activity, BMI, visceral fat, and markers of inflammation, without asking people to change what they ate. With 35 participants over 12 weeks, this is a pilot rather than a definitive result. Larger and longer trials are needed, but the early evidence is worth following for people living with inflammatory bowel disease.

Read the full study

Get Dr. Kumar's free health protocols

Evidence-based playbooks from Dr. Ravi Kumar, MD, a board-certified neurosurgeon, plus a weekly research review. Enter your email and I'll send you the relevant protocol.

By subscribing, you agree to receive emails from The Dr Kumar Discovery. You can unsubscribe at any time. Privacy Policy

The Dr Kumar Discovery Podcast
Podcast

The Dr Kumar Discovery

Where science meets common sense. Practical, unbiased answers to today's biggest health questions.

Browse all episodes →